Szajer Katarzynar, Karakuła Hanna, Pawezka Justyna, Grzywa Anna, Przywara Grzegorz, Gut Adam
Klinika Psychiatrii AM, Lublinie.
Psychiatr Pol. 2005 May-Jun;39(3):519-26.
The aim of the third part of our work, associated with psychopharmacotherapy during pregnancy and lactation is to present guidelines of expert--groups concerning the current rules of treating anxiety, obsessive--compulsive and sleep disorders and actual data about spreading of these disorders, pre- and perinatal effects of drugs used and the classification of them according to FDA and the safety of these medications for the breast fed newborn.
我们工作的第三部分与孕期及哺乳期的心理药物治疗相关,其目的是介绍专家小组关于治疗焦虑症、强迫症和睡眠障碍的现行规则指南,以及这些疾病的传播实际数据、所用药物的产前和围产期影响、根据美国食品药品监督管理局(FDA)对这些药物的分类,以及这些药物对母乳喂养新生儿的安全性。